Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Acutely Elevated Afterload on Left Ventricular Contractility and Relaxation (ANREP-EF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02751853
Recruitment Status : Recruiting
First Posted : April 26, 2016
Last Update Posted : September 26, 2019
Sponsor:
Information provided by (Responsible Party):
Holger Thiele, University of Luebeck

Brief Summary:
Aim of the study is to assess the effects of abruptly increased afterload on left ventricular contractility and relaxation in patients with heart failure with preserved ejection fraction (HFPEF), patients with heart failure with reduced ejection fraction (HFREF), and patients without HFPEF or HFREF.

Condition or disease Intervention/treatment Phase
Heart Failure Device: Conductance catheter Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Effects of Acutely Elevated Afterload oN Left VentRicular Contractility and RElaxation in Heart Failure With Preserved and Reduced Ejection Fraction
Study Start Date : December 2016
Estimated Primary Completion Date : May 2020
Estimated Study Completion Date : August 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure

Arm Intervention/treatment
Experimental: HFPEF
Patient with heart failure with preserved ejection fraction (HFPEF)
Device: Conductance catheter
Continuous online measurements of left ventricular pressure and volume using conductance catheters

Experimental: HFREF
Patient with heart failure with reduced ejection fraction (HFREF)
Device: Conductance catheter
Continuous online measurements of left ventricular pressure and volume using conductance catheters

Active Comparator: No HFPEF/HFREF
Patient without heart failure with preserved ejection fraction (HFPEF) or heart failure with reduced ejection fraction (HFREF)
Device: Conductance catheter
Continuous online measurements of left ventricular pressure and volume using conductance catheters




Primary Outcome Measures :
  1. Hemodynamic parameter 1: Changes in contractility assessed by the end-systolic pressure-volume relationship [ Time Frame: Day 1 ]
    Changes in contractility after handgrip exercise assessed by the end-systolic pressure-volume relationship


Secondary Outcome Measures :
  1. Hemodynamic parameter 2: Changes in contractility assessed by the peak power index [ Time Frame: Day 1 ]
    Changes in contractility after handgrip exercise assessed by the peak power index

  2. Hemodynamic parameter 3: Changes in relaxation assessed by the relaxation constant "tau" [ Time Frame: Day 1 ]
    Changes in relaxation after handgrip exercise assessed by the relaxation constant "tau"

  3. Functional parameter: Changes in ejection fraction [ Time Frame: Day 1 ]
    Changes in ejection fraction after handgrip exercise assessed by echocardiography



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical indication for left and right heart catheterization
  • HFPEF (Group 1) OR HFREF (Group 2) OR absent echocardiographic evidence of HFREF OR HFPEF(Group 3)

AND

  • Sinus rhythm during invasive measurements
  • Age ≥18 years
  • Negative pregnancy test in women with childbearing potential
  • Written informed consent

Exclusion Criteria:

  • Acute coronary syndrome
  • Acute myocardial infarction <6 months
  • Planned cardiac surgery or cardiovascular intervention within 6 months following inclusion
  • Valvular heart disease >2°
  • Severe comorbidities with limited life expectancy <12 months
  • Precapillary pulmonary hypertension
  • Participation in another trial

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02751853


Locations
Layout table for location information
Germany
Universitätsklinikum Schleswig-Holstein Recruiting
Lübeck, Schleswig-Holstein, Germany, 23538
Contact: Jan Reil, MD    +49 451 500 44542    jan-christian.reil@uksh.de   
Principal Investigator: Jan Reil, MD         
Sponsors and Collaborators
University of Luebeck
Layout table for additonal information
Responsible Party: Holger Thiele, Director, Department of Cardiology, Angiology, and Intensive Care Medicine, University Heart Center Luebeck, University of Luebeck
ClinicalTrials.gov Identifier: NCT02751853    
Other Study ID Numbers: 16-011
First Posted: April 26, 2016    Key Record Dates
Last Update Posted: September 26, 2019
Last Verified: September 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Heart Diseases
Cardiovascular Diseases